ArticleClinical & translational immunology2022
Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide.
Fariba Poosti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it